AstraZeneca boosted by good results for biotech asthma drug – Reuters


Reuters

AstraZeneca boosted by good results for biotech asthma drug
Reuters
LONDON AstraZeneca's (AZN.L) drive to rebuild its portfolio of new medicines received a boost on Tuesday with positive results for a biotech drug for severe asthma that the company has previously flagged as a potential $2 billion-a-year product.
AstraZeneca: Asthma drug trial results positiveMarketWatch
Astrazeneca Reports Results On Benralizumab Phase III Programme In Severe AsthmaNasdaq
TOP NEWS: AstraZeneca Gets Positive Benralizumab Phase III Trial ResultsLondon South East (registration) (blog)

all 4 news articles »

View full post on asthma – Google News

Asthma risks ‘may be boosted by energy efficient homes’ – Medical News Today


cornishguardian.co.uk

Asthma risks 'may be boosted by energy efficient homes'
Medical News Today
However, the new study – published in the journal Environment International – argues that behavioral changes are needed to avoid this drive toward energy efficient homes boosting asthma risk. The UK, the researchers remind, has one of the highest …
Energy Efficient Homes Linked to Greater Risk of AsthmaYouth Health Magzine
Energy-efficient homes may trigger asthmaFree press journal
Energy efficient houses could increase risk of developing asthma, researchers cornishguardian.co.uk

all 4 news articles »

View full post on asthma – Google News

Global asthma market to hit $18 billion by 2021 boosted by biologics – The Pharma Letter


The Pharma Letter

Global asthma market to hit $18 billion by 2021 boosted by biologics
The Pharma Letter
Natasha Spiller, an analyst at Datamonitor Healthcare said: “Severe asthma remains a significant cause of mortality and morbidity and a portion of patients remain inadequately treated, despite the use of inhaled corticosteroids and long-acting beta 2

View full post on asthma – Google News

Asthma Hospitalization Rates in Kids Boosted by High Copays – Medscape

Asthma Hospitalization Rates in Kids Boosted by High Copays
Medscape
March 30, 2012 — Higher copays are linked to a slight decrease in asthma medication use and to a statistically significant increase for hospitalization among older children, according to a study published in the March 28 issue of JAMA.
High co-pays linked to increased health risks for kids with asthmaMinnPost.com
Lower copays help ensure medication adherenceFierceHealthPayer

all 2 news articles »

View full post on asthma – Google News

Asthma Affects 1 in 12 of the Population in the UK

A new study will shed light on late phase of asthma attacks

Press reports by the Imperial College London reflect that Asthma affects 1 in 12 of the population in the UK, with 5.4 million people currently receiving treatment. The UK has the highest prevalence of asthma in young adults in Europe and the numbers of children reporting asthma symptoms has risen six fold over the last 30.

A new grant from the Medical Research Council and GlaxoSmithKline will enable researchers to investigate mechanisms of potentially life-threatening asthma attacks. Research into acute asthma attacks boosted with £4m award

The grant, to the MRC-Asthma UK Centre in Allergic Mechanisms of Asthma at Imperial College London and King’s College London, will enable researchers to investigate how acute asthma attacks, which can be life-threatening and are often resistant to the few available treatments, are linked to allergy and viral infection. Professor Sebastian Johnston of Imperial College London and Dr Roberto Solari of GSK will lead three teams of scientists at Imperial, King’s and GSK to explore novel mechanisms of disease and identify potential targets for the development of new treatments.

Professor Johnston, Director of the MRC-Asthma UK Centre in Allergic Mechanisms of Asthma at Imperial, said: ”This is a wonderful opportunity to combine the unique clinical models we have developed at Imperial with truly cutting edge science at King’s and drug discovery expertise at GSK, into a new alliance to boost efforts to develop new therapies for this huge unmet medical need”

Professor Stephen Holgate, Chair of the MRC Population and Systems Medicine Board said: “The human immune system provides vital protection from a vast array of diseases, but in some cases – such as asthma and allergy – it can be our worst enemy. This important investment by the MRC and GSK will help to advance our understanding of how these conditions interact at a molecular level, which we hope will inform new, effective and targeted therapies that make a real difference to patients.”

Roberto Solari, from GlaxoSmithKline Respiratory Drug Discovery, said: “GSK has a strong heritage of over 40 years experience in respiratory research and medicines. This is an exciting partnership for GSK to be involved in, examining state of the art science and bringing together experts in the field of asthma research. Gaining further understanding of the role viral infections might have in the development of allergic asthma could offer potential to unlock science that will help to develop future treatments and improve the lives of patients.”

Dr Samantha Walker, Executive Director of Research and Policy at Asthma UK, said: “This programme of research will be vital in exploring potential new treatments for asthma, a condition that still kills over 1,000 people every year in the UK. Despite the fact that asthma affects around 5.4 million people, research into asthma is under-resourced and so this funding is a huge boost. We hope the programme will lead to the discovery of new, life-changing treatments, particularly for the thousands of people whose asthma is resistant to current medicines.”

The MRC-Asthma UK Centre in Allergic Mechanisms of Asthma was established in 2006 to unite two hubs of asthma research expertise at King’s and Imperial into a single, world-leading Centre.

Kid asthma ‘boosted by’ Calpol use – Mirror.co.uk


TopNews New Zealand

Kid asthma 'boosted by' Calpol use
Mirror.co.uk
Babies who are given Calpol are twice as likely to develop asthma, a new study claims. Children fed the medicine – or other
Paracetamol linked to asthma riskStuff.co.nz
Asthma may be linked to paracetamolOtago Daily Times
Reassurance over paracetamolNZ City
HealthJockey.com –TopNews New Zealand –Express.co.uk
all 94 news articles »

View full post on asthma – Google News